The Daily Brief for Benefits Professionals
BenefitsWire
Health & Welfare Plans
November 2, 2026
— § —
13 items · ~3 min read
In this issue
Regulatory Action and Guidance (10) · Litigation (2) · General Benefits (1)
Regulatory Action and Guidance
10 items⏱ Effective Jan 4
The Department of Labor issued a final rule requiring pharmacy benefit managers to disclose their compensation to fiduciaries of large, self-insured group health plans, enabling fiduciaries to assess contract reasonableness and potentially lower drug costs. MORE >>
Source: Department of Labor
“By: Tony Roda, Williams & Jensen PLLC With a late October deadline for this article, it became an obvious challenge to write about the next Congress without first knowing the outcome of the November 3 elections.” MORE >>
Source: NCPERS
“Find Your Next Job ! Federal efforts to bring greater transparency to pharmacy benefit manager (“PBM”) compensation are advancing. On October 29, 2026, the Department of Labor (“DOL”) released its final PBM compensation disclosure rule for large, self-insured ERISA health plans (“Final Rule”).” MORE >>
Source: Sheppard Mullin
“Forgot Your Password? If you do not yet have an ERIC Online profile or user name and password, please create one using Create Profile Form. If you need assistance with your user name/password or profile, please contact ERIC at (202) 789-1400.” MORE >>
Source: ERIC
“On October 28, 2026, HHS issued the document, HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances(“limited enforcement discretion policy”). FDA’s future rulemaking may propose adding some or all of these substances to the bulks list. Key Circumstances to be Met for Limited Enforcement Discretion: This “limited enforcement discretion policy” states that the Secretary of HHS has determined that, if all specified circumstances are met, HHS does not intend to take enforcement action against covered compounders using these six peptide bulk drug substances.” MORE >>
Source: Foley & Lardner
The Department of Labor's final rule mandates PBMs disclose hidden fees and compensation to employers, enhancing transparency in prescription drug costs and aiming to lower expenses for American families. MORE >>
Source: House Education & Workforce Committee
“On October 29, 2026, a federal district court in Massachusetts struck down part of CMS’s Medicaid community engagement rule, ruling that CMS exceeded its statutory authority by narrowing the definition of “medically frail” individuals who may qualify for an exemption from the new requirements. The court’s decision to set aside the challenged requirement applies nationwide, while its injunction against enforcement applies only to the 25 plaintiff states and the District of Columbia.” MORE >>
Source: Groom Law Group
“The much-anticipated final rule updating requirements for insurers and group health plans to publish negotiated prices has cleared the White House Office of Management and Budget.” MORE >>
Source: insidehealthpolicy.com
CMS finalized updates to the End-Stage Renal Disease (ESRD) Prospective Payment System for 2027, including revisions to payment rates for acute kidney injury dialysis and the ESRD Quality Incentive Program. MORE >>
Source: Federal Register
“Last week, the Department of Labor’s Employee Benefits Security Administration released a rule requiring PBMs and their affiliated brokers and consultants to disclose the fees and compensation they receive, so employers can negotiate contracts and seek lower prescription drug costs for their customers. The agency projected the rule would lower prescription drug costs by up to $22 billion over 10 years. Additionally, the final rule provides important compliance-assistance information for all service providers to employer-sponsored group health plans, which are now required to report fees and compensation to group health plan fiduciaries in initial plan and semi-annual disclosures.” MORE >>
Source: ncpa.org
Litigation
2 items“In a unanimous opinion, a three-judge panel of the Ninth Circuit held that California’s ban on “captive-audience” meetings violates the First Amendment. The court explained that the ban regulates speech based on the speech’s content. As a content-based regulation, the ban triggered the strictest level of constitutional review—“strict scrutiny.” The ban could not pass that test.” MORE >>
Source: Littler
“66 Franklin Street, Suite 300 Oakland, CA 94607 Williamson v. Life Insurance Company of North America, No. 25-5790, 2026 WL 3153191 (6th Cir. Oct. 21, 2026) (Before: Kethledge, Chief Judge; Cole and Mathis, Circuit Judges).” MORE >>
Source: Roberts Disability Law
General Benefits
1 item“06.30.2026 New York, NY Kevin Lowell will speak at the American Health Law Association (AHLA) Annual Meeting and In-House Counsel Program on June 30, 2026. Lowell will present, as a part of a panel, "Key Considerations in Responding to a Corporate Criminal Healthcare Case.” MORE >>
Source: Hall Benefits Law
Also of Note
- NCPERS Launches New Roundtable for Pension Technology Leaders — “This fall, we will be launching a new Technology Leaders Roundtable to bring together decision-makers at public pensions to discuss information technology, information security, AI, modernization, data management, and more.” (NCPERS)
- What happens to a health plan’s payment operation when volume triples — “Health plans receive 98% of medical claims electronically. They pay only 78% of them by electronic funds transfer (EFT).” (Healthcare Dive)
- Healthcare employers are planning for growth. Are they watching the right roles? — “The pressure is becoming more urgent as the private healthcare and social assistance sector is projected to add more than 2.” (Healthcare Dive)
- Understanding the Complexity Premium in Lower Middle Market Asset-Backed Specialty Finance — “A complexity premium is the additional yield earned for providing capital to transactions that are difficult to source, analyze, structure, document, monitor, or manage.” (NCPERS)